Survey on current ICU care for ARDS in Europe
Part of Lungs & breathing clinical trials.
This study is a survey that asks doctors and nurses from ICUs across Europe how they currently treat ARDS, a serious lung condition. Your answers will help show what really happens in hospitals and could guide better care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthcare professional (such as a doctor or nurse) working in an intensive care unit (ICU).
- Your ICU cares for patients with ARDS, a serious breathing condition.
- You are actively involved in treating or managing these ARDS patients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some patients develop severe breathing problems in the ICU. It focuses on people who already have conditions like severe infections, injuries, or heavy bleeding that can stress the lungs.
This study is for patients in the ICU with ARDS (a severe lung condition). It looks at biomarkers (special substances in your blood) to help understand different types of ARDS. You do not receive any treatment, but you help researchers learn more about the disease.
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
This study looks at how doctors safely remove breathing tubes from patients with lung injury (ARDS). It aims to find ways to improve decisions about when to take the tube out.
This trial tests a new way of setting the breathing machine for people with a lung condition called ARDS. It may help improve breathing and recovery compared to standard care.
This study collects health information from ICU patients with or at high risk for ARDS to better understand the condition and develop a tool to help doctors make decisions. It may not directly help you, but it could improve care for future patients.
Hear when a new ARDS (Acute Respiratory Distress Syndrome) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.